Adam N Rosenthal

Adam N Rosenthal

UNVERIFIED PROFILE

Are you Adam N Rosenthal?   Register this Author

Register author
Adam N Rosenthal

Adam N Rosenthal

Publications by authors named "Adam N Rosenthal"

Are you Adam N Rosenthal?   Register this Author

26Publications

487Reads

18Profile Views

Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.

Ophthalmology 2018 11 5;125(11):1765-1775. Epub 2018 Jun 5.

NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital and University College London, London, United Kingdom; Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; Institute of Ophthalmology, University College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2018.04.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195794PMC
November 2018

Anal High-Grade Squamous Intraepithelial Lesions in Pharmacologically Immunocompromised Patients Followed in a Referral Center.

Dis Colon Rectum 2018 11;61(11):1267-1272

Homerton Anal Neoplasia Service, Homerton University Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0000000000001214DOI Listing
November 2018

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

J Clin Oncol 2017 May 27;35(13):1411-1420. Epub 2017 Feb 27.

Adam N. Rosenthal, Lindsay S.M. Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Andy Ryan, Robert Liston, Jeremy Ford, Richard Gunu, Usha Menon, and Ian J. Jacobs, University College London Elizabeth Garrett Anderson Institute for Women's Health; Elizabeth Benjamin, University College London; Naveena Singh, Barts Health National Health Service Trust; Ranjit Manchanda, Barts Cancer Institute, Queen Mary University of London; Anne Dawnay, University College London Hospital; James Mackay, The University College London Cancer Institute, London; D. Gareth Evans, University of Manchester, St Mary's Hospital Manchester, Manchester; Diana M. Eccles, Southampton General Hospital, Southampton, United Kingdom; Steven J. Skates, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and Ian J. Jacobs, University of New South Wales Australia, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.9330
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.9330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455461PMC
May 2017

Media must report celebrity health stories responsibly.

Authors:
Adam N Rosenthal

BMJ 2017 Jan 16;356:j192. Epub 2017 Jan 16.

University College London Hospitals NHS Foundation Trust, Gynaecology Cancer Research Centre, 1st Floor, Maple House, London W1T 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.j192DOI Listing
January 2017

Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients.

Int J Gynaecol Obstet 2016 May 28;133(2):239-40. Epub 2015 Dec 28.

Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2015.09.013DOI Listing
May 2016

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.

J Natl Cancer Inst 2015 Nov 27;107(11). Epub 2015 Aug 27.

Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA (SJR, MPI, CKE, DC, SAG); CR-UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (HS, ED, JPT, PH, JA, PDPP); Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK (ANR, LF, AGM, JH, SP, CA, UM, IJJ); Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (DB, ACA); Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia (DDB, KA, GM, AOCSSG); Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia (DDB); Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia (DDB, GM); Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK (DDB); Westmead Millennium Institute, Westmead Hospital, Sydney, Australia (AOCSSG); The QIMR Berghofer Medical Research Institute, Brisbane, Australia (AOCSSG); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (MSC, JMC, ELG); Department of Biostatistics, University of Kansas Medical Center, Andover, KS (BLF); Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK (MJL); Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY (SP, SL, KO); Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY (LSC, KBM); Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA (WS, VM, ASW); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center (JL, BYK); Gynaecology Research Unit, Hannover Medical School, Hannover, Germany (NB, TD); Radiation Oncology Research Unit, Hannover Medical School, Hannover,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643629PMC
November 2015

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

BJOG 2014 Dec;121 Suppl 7:35-9

Gynaecology Cancer Research Unit, St Bartholomew's Hospital, The Royal Hospitals NHS Trust, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1471-0528.13211DOI Listing
December 2014

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.

Lancet Oncol 2013 Nov 17;14(12):1226-32. Epub 2013 Oct 17.

Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70448-0DOI Listing
November 2013

Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach.

BMC Womens Health 2013 Nov 13;13:45. Epub 2013 Nov 13.

Kings College London Promoting Early Presentation Group, 9th Floor Capital House, 42 Weston Street, London SE1 3QD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6874-13-45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835395PMC
November 2013

Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS).

Arch Gynecol Obstet 2012 Dec 4;286(6):1555-62. Epub 2012 Aug 4.

Department of Gynaecological Oncology, EGA Institute for Women's Health, Gynaecological Cancer Research Centre, University College London, and Department of Gynaecology, University College London Hospital, First floor, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-012-2492-2DOI Listing
December 2012

Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harm.

Gynecol Oncol 2012 Dec 31;127(3):556-63. Epub 2012 Aug 31.

Cochrane Institute of Primary Care and Public Health, Neuadd Meirionnydd, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4YS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.08.034DOI Listing
December 2012

Fooled by the film: delayed diagnosis of incarcerated small-bowel hernia after laparoscopic surgery for endometrial cancer.

Int J Gynecol Cancer 2012 Feb;22(2):337-9

Barts Cancer Institute, A Cancer Research UK Centre of Excellence, Barts and the London School of Medicine and Dentistry, London, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31823c244bDOI Listing
February 2012

Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma?

Int J Gynecol Cancer 2011 Oct;21(7):1297-305

Department of Gynaecological Oncology, Barts and the London NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31822dbe26DOI Listing
October 2011

Screening for ovarian cancer.

Clin Obstet Gynecol 2006 Sep;49(3):433-47

Institute for Women's Health, University College London, Elizabeth Garrett Anderson Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00003081-200609000-00004DOI Listing
September 2006

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

J Clin Oncol 2005 Nov;23(31):7919-26

Department of Gynecological Oncology, Institute of Women's Health, University College London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.6642DOI Listing
November 2005

Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases.

Int J Cancer 2002 Jun;99(4):549-54

Gynaecological Oncology Unit, St. Bartholomew's and Royal London Hospitals Medical College, Queen Mary and Westfield College, Charterhouse Square, London EC1M 6GM, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10362DOI Listing
June 2002